risk of semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss Semaglutide linked to reduced risk

this observation suggests that inactivation of the GPx3 gene by hypermethylation of the promoter may contribute to breast cancer progression

Perhaps more concerning is that 11 to 50% of total weight loss in GLP-1 RA users is attributed to loss of lean body mass, which may detrimentally include loss of skeletal muscle 26 , potentially negatively impacting metabolism, strength and long-term health

human clinical data is limited

If less than 1 gram of the substance will dissolve in 100 milliliters (or 100 g) of solvent, the substance is considered insoluble

Early research suggested that the tripeptide bonds of standard generic glutathione were rapidly degraded by peptidases and stomach acids in the gastrointestinal tract, leading to poor systemic bioavailability